Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.3K Sell
100
-3
-3% -$1.54K ﹤0.01% 870
2026
Q1
$44.7K Hold
103
﹤0.01% 864
2025
Q4
$33.8K Buy
103
+3
+3% +$964 ﹤0.01% 884
2025
Q3
$32K Hold
100
﹤0.01% 886
2025
Q2
$27.5K Hold
100
﹤0.01% 911
2025
Q1
$18.4K Hold
100
﹤0.01% 981
2024
Q4
$19.7K Hold
100
﹤0.01% 970
2024
Q3
$20.8K Hold
100
﹤0.01% 942
2024
Q2
$23.5K Hold
100
﹤0.01% 912
2024
Q1
$17.7K Hold
100
﹤0.01% 982
2023
Q4
$13.7K Hold
100
﹤0.01% 1022
2023
Q3
$11.2K Buy
+100
New +$11.8K ﹤0.01% 1036

Other funds holding NVMI

Central Trust Company's NVMI Position: Q2 2026 in Review

Central Trust Company reduced its Nova (NVMI) stake by 2.9% in Q2 2026, selling an estimated $1.54K and leaving 100 shares worth $54.3K. The position accounts for ﹤0.01% of the portfolio, ranked #870.

Central Trust Company first reported a position in NVMI in Q3 2023 and has held it in 12 quarters since. 345 funds tracked by Wall St. Rank hold NVMI as of Q2 2026.

  • Central Trust Company held 100 shares of Nova worth $54.3K as of Q2 2026.
  • Central Trust Company sold 3 Nova shares in Q2 2026, an estimated $1.54K.
  • Nova made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #870 holding.
  • Central Trust Company first reported a position in Nova in Q3 2023 and has held it in 12 quarters since.
  • 345 funds tracked by Wall St. Rank held Nova as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.